Winter Fluorine 2023
Attendee Safety Plan
Effective: May 27, 2022 – Subject to Change

To promote the safety of everyone at the event, the ACS Division of Fluorine Chemistry will follow the guidelines and requirements of the CDC, State of Florida, Florida Department of Health, and other local regulations regarding COVID safety practices. This Attendee Safety Plan may change from time to time until the start of and during the 26th Winter Fluorine Conference.

 IMPORTANT: In light of the events surrounding COVID-19, this is an appropriate time to remind ourselves of the risks incident to be participating in the 26th Winter Fluorine Conference. Even with every reasonable precaution to keep you safe as outlined for you by the CDC, the ACS Division of Fluorine Chemistry cannot fully eliminate all risks of harm to attendees or guarantee their safety, especially from risks posed by COVID-19 or its variant strains. Ultimately you are responsible for your own safety.

Failure to adhere to the following requirements could lead to removal from the venue or other disciplinary action. 

Vaccination Requirements:

  • 26th Winter Fluorine Conference will be a will be Vaccination Required or proof of a negative COVID-19 PCR Test meeting for all attendees, exhibitors, vendors, and ACS staff who seek to gain access to the in-person meeting in Clearwater, Florida.
  • All attendees must be fully vaccinated against COVID-19 by December 25, 2022, 14 days from the start of the meeting, or provide proof of a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference.
  • All attendees who are fully vaccinated against COVID-19 are required to provide proof of vaccination. Individuals will receive further instructions in late November or early December. 
  • This guidance applies to COVID-19 vaccines authorized for use and for emergency use by the U.S. Food and Drug Administration (i.e., Pfizer-BioNTech, Moderna, and Johnson and Johnson's Janssen COVID-19 vaccines), and COVID-19 vaccines authorized for emergency use by the World Health Organization (WHO) (i.e. Pfizer-BioNTech, Moderna, and Johnson and Johnson's Janssen, Oxford/AstraZeneca, Covishield, Covaxin, Sinopharm/BBIBP-CorV, and Sinovac/CoronaVac), on or before July 24, 2022. The full list of vaccines with final WHO EUL/PQ evaluation status is available here. ACS Division of Fluorine Chemistry may expand the list of vaccines, provide more specific guidance regarding mixed vaccination dosing, and/or provide additional guidance regarding boosters as prevailing public health guidance evolves. Watch this space for additional details as we get closer to Winter Fluorine 2023. 
  • According to the Centers for Disease Control (CDC), people are considered fully vaccinated for COVID-19 two weeks after they have received the second dose in a two-dose series (Pfizer/BioNTech or Moderna), or two weeks after they have received a single-dose vaccine of Johnson & Johnson’s Janssen.
  • Additional restrictions on participants may come in accordance with the Center for Disease Control and Prevention (CDC) guidelines and applicable federal, state, or local governmental orders, regulations, and/or guidelines intended to reduce the spread and risks of exposure to COVID-19.

Mask Requirements:

  • ACS Division of Fluorine Chemistry is recommending that all Winter Fluorine 2023 attendees, exhibitors, vendors, and ACS staff wear a face mask while in the Hyatt Regency Clearwater Beach Resort and Spa, or any facility hosting a Winter Fluorine-sponsored event or meeting, or while attending a Winter Fluorine hosted/sponsored events or meetings.
  • A recommended mask should be made of at least 2 layers of breathable fabric or hospital grade material, fully covers the nose, nostrils, mouth, and fits firmly under the chin, and fits snugly, but comfortably against the side of the face. 

Do Not Attend if… 
All attendees, exhibitors and staff should NOT ATTEND if:

  • Unvaccinated, all unvaccinated individuals or individuals who do not provide a negative COVID-19 PCR test that has been taken within 48 hours of arriving at the conference will be denied entry.
  • Vaccinated and having underlying COVID-19 related risk factors.
  • Exhibiting any symptoms or signs of sickness or have been in contact with known positive COVID-19 cases within 10 days of Winter Fluorine 2023.
  • Testing positive for COVID-19 within the last 10 days from the start of Winter Fluorine 2023.
  • Have had contact with a person that has or is suspected of having COVID-19 within fourteen (14) days from the start of Winter Fluorine 2023 and have not completed a quarantine protocol.

Traveling to Attend 

  • Fully vaccinated travelers should still follow   CDC’s recommendations for traveling safely including wear a mask, stay 6 feet from others, and wash your hands or use hand sanitizer.
  • If fully vaccinated with an FDA-authorized vaccine or a vaccine authorized for emergency use by the World Health Organization one can travel safely within the United States.
  • Fully vaccinated domestic travelers do not need to get tested before or after travel unless their destination requires it. U.S bound international travelers will need to be tested no more than 3 days before arrival in the U.S. and show your negative test result to the airline before you board the flight. Check with the CDC for guidelines on using some self-COVID-19 tests to meet entry.

Additional Safety Measures: 

  • Physical distancing in meeting rooms whenever space allows.
  • Hand sanitizer stations will be located throughout the meeting space. It is the responsibility of each person to maintain personal hygiene, including washing your hands frequently for at least 20 seconds with soap and warm water.
  • Disinfectant wipes will also be available in every breakout room for disinfecting high-touch items used by presenters.
  • Please observe physical distancing guidelines when greeting others. ACS Division of Fluorine Chemistry discourages handshaking, hugging, or any other unnecessary person-to-person contact.
  • COVID-safe catering. 

Contact Tracing & Privacy 

  • All attendees will be required to provide a working phone number to ACS Division of Fluorine Chemistry at the time of registration in case ACS Division of Fluorine Chemistry is notified by any government or local health department that contact tracing is required.
  • The privacy of all attendees relative COVID-19 related situations will be respected at all times, including the secure and limited access to their data and the proper and timely disposal post-meeting.

COVID-19 TESTING STATION
(Closest PCR COVID-19 Testing Station Near Hotel)

Walgreens 703 Court St.
Clearwater, FL 33756
727.447.3188

COVID Testing Sites in Clearwater and Surrounding Areas

HOSPITAL
(Closet Hospital Near Hotel)

Morton Plant Hospital
300 Pinellas Street Clearwater, FL 33756
727.462.7000

SAFETY PROTOCOLS

Hotel Safety Protocols

World of Hyatt Safety Protocols

Florida COVID-19 Response

Local County COVID-19 Response

Latest from the CDC

Advice from the World Health Organization

TRANSPORTATION

Travel Guidelines from the CDC 

International Travel

TSA Guidelines 

American Airlines 

Delta Airlines 

Southwest Airlines

United Airlines

Conference Contacts


Conference Chair
David Vicic
H. S. Bunn Distinguished Professor
Department of Chemistry, Lehigh University
6 E. Packer Ave.
Bethlehem, PA 18015
Tel: 610-758-3466
Email: vicic@lehigh.edu

Conference Co-Chair
Thomas Mathew
Research Scientist
Loker Hydrocarbon Research Institute
University of Southern California
Los Angeles, CA 90089-1661
Tel: 714-469-3806
Email: tmathew@usc.edu

 

Housing and Registration Questions?

Email: winterfluorine@acs.org

ACS © 2022 Copyright - 26th Winter Conference - All Rights Reserved.